nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CCL2—intracranial aneurysm	0.964	1	CbGaD
Danazol—CCL2—IL1 and megakaryotyces in obesity—TIMP2—intracranial aneurysm	0.00744	0.283	CbGpPWpGaD
Danazol—CCL2—IL1 and megakaryotyces in obesity—TIMP1—intracranial aneurysm	0.00246	0.0935	CbGpPWpGaD
Danazol—CCL2—artery—intracranial aneurysm	0.0021	0.215	CbGeAlD
Danazol—AR—Notch-mediated HES/HEY network—RBBP8—intracranial aneurysm	0.00129	0.0491	CbGpPWpGaD
Danazol—GNRHR—brainstem—intracranial aneurysm	0.00114	0.117	CbGeAlD
Danazol—PGR—artery—intracranial aneurysm	0.0011	0.113	CbGeAlD
Danazol—CCL2—AP-1 transcription factor network—TIMP1—intracranial aneurysm	0.00104	0.0397	CbGpPWpGaD
Danazol—GNRHR—Peptide GPCRs—EDNRA—intracranial aneurysm	0.000936	0.0356	CbGpPWpGaD
Danazol—CCL2—IL1 and megakaryotyces in obesity—MMP9—intracranial aneurysm	0.000888	0.0338	CbGpPWpGaD
Danazol—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—intracranial aneurysm	0.000836	0.0318	CbGpPWpGaD
Danazol—GNRHR—GPCRs, Other—EDNRA—intracranial aneurysm	0.000794	0.0302	CbGpPWpGaD
Danazol—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—intracranial aneurysm	0.000783	0.0298	CbGpPWpGaD
Danazol—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—intracranial aneurysm	0.000628	0.0239	CbGpPWpGaD
Danazol—CCL2—medulla oblongata—intracranial aneurysm	0.000622	0.0637	CbGeAlD
Danazol—CCL2—midbrain—intracranial aneurysm	0.000569	0.0582	CbGeAlD
Danazol—CCL2—TWEAK Signaling Pathway—MMP9—intracranial aneurysm	0.000568	0.0216	CbGpPWpGaD
Danazol—GNRHR—cerebellum—intracranial aneurysm	0.000564	0.0577	CbGeAlD
Danazol—SHBG—brainstem—intracranial aneurysm	0.000521	0.0533	CbGeAlD
Danazol—CCL2—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.000481	0.0183	CbGpPWpGaD
Danazol—GNRHR—brain—intracranial aneurysm	0.000458	0.0469	CbGeAlD
Danazol—GNRHR—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.000446	0.017	CbGpPWpGaD
Danazol—CCL2—cerebellum—intracranial aneurysm	0.00044	0.045	CbGeAlD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.000399	0.0152	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—MMP9—intracranial aneurysm	0.000377	0.0144	CbGpPWpGaD
Danazol—ESR1—brainstem—intracranial aneurysm	0.000367	0.0376	CbGeAlD
Danazol—CCL2—brain—intracranial aneurysm	0.000357	0.0366	CbGeAlD
Danazol—ESR1—AP-1 transcription factor network—TIMP1—intracranial aneurysm	0.000353	0.0134	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—STARD13—intracranial aneurysm	0.000342	0.013	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000323	0.0123	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—STARD13—intracranial aneurysm	0.000313	0.0119	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000295	0.0112	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—MMP2—intracranial aneurysm	0.000261	0.00992	CbGpPWpGaD
Danazol—SHBG—cerebellum—intracranial aneurysm	0.000257	0.0263	CbGeAlD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.000257	0.00976	CbGpPWpGaD
Danazol—ESR1—FOXM1 transcription factor network—MMP2—intracranial aneurysm	0.000256	0.00973	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—MMP9—intracranial aneurysm	0.000248	0.00945	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000246	0.00936	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—NOS3—intracranial aneurysm	0.000244	0.00929	CbGpPWpGaD
Danazol—PGR—cerebellum—intracranial aneurysm	0.000231	0.0237	CbGeAlD
Danazol—GNRHR—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000225	0.00856	CbGpPWpGaD
Danazol—SHBG—brain—intracranial aneurysm	0.000208	0.0213	CbGeAlD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—intracranial aneurysm	0.000198	0.00754	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.000198	0.00752	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—STARD13—intracranial aneurysm	0.000197	0.0075	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—intracranial aneurysm	0.000196	0.00745	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—MMP2—intracranial aneurysm	0.000195	0.00741	CbGpPWpGaD
Danazol—PGR—brain—intracranial aneurysm	0.000188	0.0192	CbGeAlD
Danazol—ESR1—cerebellum—intracranial aneurysm	0.000181	0.0185	CbGeAlD
Danazol—ESR1—AP-1 transcription factor network—CCL2—intracranial aneurysm	0.000179	0.00679	CbGpPWpGaD
Danazol—CYP19A1—brain—intracranial aneurysm	0.000169	0.0173	CbGeAlD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000159	0.00606	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—NOS3—intracranial aneurysm	0.000151	0.00573	CbGpPWpGaD
Danazol—AR—brain—intracranial aneurysm	0.00015	0.0153	CbGeAlD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—intracranial aneurysm	0.000149	0.00567	CbGpPWpGaD
Danazol—ESR1—brain—intracranial aneurysm	0.000147	0.015	CbGeAlD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000146	0.00554	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—MMP9—intracranial aneurysm	0.000128	0.00486	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000127	0.00484	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000126	0.0048	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STARD13—intracranial aneurysm	0.000116	0.0044	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000115	0.00439	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CCL2—intracranial aneurysm	0.000111	0.00422	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SLC25A16—intracranial aneurysm	0.000107	0.00408	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—MMP2—intracranial aneurysm	8.11e-05	0.00309	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NCF1—intracranial aneurysm	7.89e-05	0.003	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EDNRA—intracranial aneurysm	7.46e-05	0.00284	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NCF1—intracranial aneurysm	7.22e-05	0.00275	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ASAH1—intracranial aneurysm	7.1e-05	0.0027	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EDNRA—intracranial aneurysm	6.82e-05	0.00259	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CCL2—intracranial aneurysm	5.69e-05	0.00216	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NCF1—intracranial aneurysm	4.55e-05	0.00173	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EDNRA—intracranial aneurysm	4.3e-05	0.00164	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCL2—intracranial aneurysm	3.36e-05	0.00128	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NOS3—intracranial aneurysm	3.27e-05	0.00125	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	3.13e-05	0.00119	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NOS3—intracranial aneurysm	2.99e-05	0.00114	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NCF1—intracranial aneurysm	2.67e-05	0.00102	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP9—intracranial aneurysm	2.63e-05	0.001	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EDNRA—intracranial aneurysm	2.52e-05	0.00096	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—intracranial aneurysm	2.4e-05	0.000914	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCL2—intracranial aneurysm	2.12e-05	0.000806	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	2.07e-05	0.000788	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOS3—intracranial aneurysm	1.89e-05	0.000719	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—intracranial aneurysm	1.52e-05	0.000577	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NOS3—intracranial aneurysm	1.48e-05	0.000564	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL2—intracranial aneurysm	1.24e-05	0.000473	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOS3—intracranial aneurysm	1.11e-05	0.000422	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—intracranial aneurysm	8.89e-06	0.000338	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NOS3—intracranial aneurysm	4.32e-06	0.000164	CbGpPWpGaD
